Medtronic Buys Mazor Robotics For $1.3Bn

Medtronic is straightening up as a market leader in spinal surgery after agreeing to buy the shares of Mazor Robotics that it does not already own. The $1.3bn deal builds on an existing agreement between the companies formed in May 2016 and strengthens Medtronic as the front runner in the spine robotics field.

Mazor X(TM) Robotic Guidance System (Mazor X),
• Source: Mazor Robotics Ltd.

Medtronic PLC is cementing its position in surgical robotics by paying $1.3bn for the shares of Mazor Robotics Ltd. it does not already own, the companies announced Sept. 20.

Medtronic already owned 11% of the company and agreed to pay approximately $1.64bn, or $1.34bn net of Medtronic’s existing stake...

More from Deals

More from Business

Additional Death And Injuries Added To 2024 Philips Ventilator Recall

 

Philips Respironics has updated instructions for use for three ventilators that were included in a May 2024 recall. The company also added three potential injuries and one death to the original number.

Ultromics Wins $55M, The Key To Success: Diagnosing Diseases With Available Treatment

 

Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.

Stryker Revises FY25 Tariff Estimate To $175M From $200M As EU Trade Pressures Mount

 
• By 

Kevin Lobo, chairman and CEO of Stryker said that the company is not as exposed to China as others and has manufacturing operations in Europe, influencing the overall tariff impact.